Zota Health Care Ltd
NSE: ZOTA BSE: 538426
₹1321
(7.01%)
Tue, 14 Apr 2026, 11:35 pm
Market Cap40.07B
PE Ratio0
Dividend0.08
Health Technology
Pharmaceuticals: Major
24.5KZota Health Care Analysis
dividend
- Dividends paid are covered by earnings (1.8x coverage).
- Zota Health Care has only been paying a dividend for 2 years, and since then dividends per share have fallen.
- Zota Health Care has been paying a dividend for less than 10 years and during this time payments have been volatile (annual drop of over 20%).
- Zota Health Care's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.75%).
- Zota Health Care's dividend is below the markets top 25% of dividend payers in India (3.1%).
health
- Zota Health Care is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Zota Health Care is profitable, therefore cash runway is not a concern.
- Zota Health Care is profitable, therefore cash runway is not a concern.
- Zota Health Care has no debt, it does not need to be covered by operating cash flow.
- Zota Health Care has no debt, it does not need to be covered by short term assets.
- Zota Health Care's cash and other short term assets cover its long term commitments.
- Zota Health Care has no debt compared to 5 years ago when it was 29.4%.
- Zota Health Care has no debt, therefore coverage of interest payments is not a concern.
- Zota Health Care has no debt.
- High level of physical assets or inventory.
management
- The tenure for the Zota Health Care board of directors is about average.
- The average tenure for the Zota Health Care management team is over 5 years, this suggests they are a seasoned and experienced team.
misc
- Zota Health Care is not covered by any analysts.
past
- Zota Health Care's 1-year earnings growth is negative, it can't be compared to the 5-year average.
- Zota Health Care's year on year earnings growth rate was negative over the past 5 years and the most recent earnings are below average.
- Zota Health Care used its assets less efficiently than the IN Pharmaceuticals industry average last year based on Return on Assets.
- Zota Health Care's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
- Zota Health Care has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
- Zota Health Care's 1-year earnings growth is negative, it can't be compared to the IN Pharmaceuticals industry average.
value
- Zota Health Care's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).
- Zota Health Care's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).
- Zota Health Care is overvalued based on assets compared to the IN Pharmaceuticals industry average.
- Zota Health Care is overvalued based on earnings compared to the IN Pharmaceuticals industry average.
- Zota Health Care is overvalued based on earnings compared to the India market.
- ZOTA underperformed the Pharmaceuticals industry which returned 24.6% over the past year.
- ZOTA underperformed the Market in India which returned -14.8% over the past year.
- NSEI:ZOTA is up 3.7% underperforming the Pharmaceuticals industry which returned 5.6% over the past month.
- NSEI:ZOTA is up 3.7% underperforming the market in India which returned 9% over the past month.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800